Myriad Pharmaceuticals Inc (NASDAQ:MYRX)

CAPS Rating: 4 out of 5

Results 1 - 17 of 17

Recs

0
Member Avatar mhy729 (33.20) Submitted: 9/9/2011 7:49:28 PM : Outperform Start Price: $1.40 MYRX Score: +41.29

Lead drug candidate suspended...this is a cash play. Following the just recently announced termination of development of Azixa, there was the expected sell-off, but there wasn't a huge drop in price and it has recovered to pre-announcement levels, so it would appear that the market is being very mindful of their cash position. The remaining drugs in the pipeline aren't terribly advanced in development, and it will be interesting to see where the newly appointed CEO will take Myrexis from here.

Recs

0
Member Avatar KMillionaire (< 20) Submitted: 12/29/2010 12:11:22 AM : Outperform Start Price: $2.14 MYRX Score: -19.18

The pipeline looks nice, but... what do I know about these things? No debt, decent amount of cash on hand. For a speculative play on an emerging biotech, you just have to follow the trend sometimes. Looks like it's trending up, to me.

Recs

0
Member Avatar cashman79 (61.64) Submitted: 9/15/2010 9:55:36 AM : Outperform Start Price: $1.99 MYRX Score: -27.21

watch

Recs

0
Member Avatar djsk (< 20) Submitted: 6/14/2010 1:37:51 PM : Outperform Start Price: $1.98 MYRX Score: -29.59

V, 5/26/10

Recs

0
Member Avatar roncool11 (< 20) Submitted: 5/27/2010 11:46:49 PM : Outperform Start Price: $2.08 MYRX Score: -36.47

lots of cash

Recs

1
Member Avatar mrindependent (89.20) Submitted: 5/25/2010 3:52:29 PM : Outperform Start Price: $2.08 MYRX Score: -41.13

Valued below cash on hand. Jumping ahead of ZZLangerhans based on his excellent may 25 blog. Going long at $4.10 prox.

Recs

0
Member Avatar jotedr (< 20) Submitted: 5/12/2010 2:39:56 AM : Outperform Start Price: $2.14 MYRX Score: -32.21

focus on Azixa trials

Recs

0
Member Avatar SmallPimpin (34.89) Submitted: 3/26/2010 10:56:15 PM : Outperform Start Price: $2.37 MYRX Score: -44.21

Mmm...pharmaceuticals...

Recs

0
Member Avatar iddqkfyou (< 20) Submitted: 2/8/2010 7:32:04 AM : Outperform Start Price: $2.17 MYRX Score: -48.98

I just think that 100millUSD is too low a valuation for a pipeline of potentially blockbuster drugs. Yes, they could dilute their shares away and trade for 10c eventually, but that is a 100% downside vs. a 1,000% upside.

I am fine with those odds because overall the biotech index trades upwards. I suspect that if you were to remove the post success biotechs from the index, the group would be doing even better. So invest pre-success and cast a wide net.

Recs

0
Member Avatar Biotech2010 (53.61) Submitted: 1/26/2010 8:56:24 PM : Outperform Start Price: $2.42 MYRX Score: -59.14

5.29

Recs

0
Member Avatar TMFBiologyFool (96.95) Submitted: 12/18/2009 10:49:15 AM : Outperform Start Price: $2.47 MYRX Score: -60.88

Trading at less than cash and pipeline is worth more than $100 million anyway.

I'm not sure about the Javelin gamble makes much sense, but at least it didn't use cash to get it.

Recs

0
Member Avatar biofest (51.06) Submitted: 12/6/2009 3:03:06 PM : Outperform Start Price: $2.82 MYRX Score: -73.41

Very undevalued. Market value $130 million, cash $181 million. 3 drus in clic; 3 preclinic.

Recs

0
Member Avatar Displacement (< 20) Submitted: 9/28/2009 3:12:28 PM : Outperform Start Price: $3.02 MYRX Score: -87.94

Taking my chances that one of their big boppers will be a winner

Recs

0
Member Avatar shastashadow (87.64) Submitted: 9/9/2009 10:35:46 PM : Outperform Start Price: $2.37 MYRX Score: -66.77

What everyone else said

Recs

0
Member Avatar mbejar (< 20) Submitted: 8/29/2009 7:23:17 PM : Outperform Start Price: $2.32 MYRX Score: -66.71

Company has no debt and 180millon dollars in the bank and a very intersting pipe line, that we should get some info by the end of year. The market cap is 110.20 millon and more cash than market value a no brainer

Recs

0
Member Avatar thomasgb (21.94) Submitted: 8/13/2009 10:20:16 AM : Outperform Start Price: $2.44 MYRX Score: -75.89

Biotech trading for less than their cash

Recs

0
Member Avatar jakethesnake9 (40.45) Submitted: 7/27/2009 11:46:07 AM : Outperform Start Price: $2.26 MYRX Score: -81.10

bought in real life at $4.50 and $4.70... definitely one of the top stocks in my real portfolio.

Results 1 - 17 of 17

Featured Broker Partners


Advertisement